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ABSTRACT:
Thiamine responsive megaloblastic anemia (TRMA) also known as Rogers syndrome is a rare entity inherited as an
autosomal recessive disorder. It consists of a pentad of diabetes-mellitus, megaloblastic anemia, thrombocytopenia,
leukopenia and sensory-neural hearing loss. The defect occurs due to mutations in SLC19A2 gene resulting in the
deficiency of a thiamine transporter proteins which prevents the transport of thiamine in to the cells and tissues. Here
we report a 13 year old boy with megaloblastic anemia, sensory-neural deafness and young onset diabetes mellitus
who presented with generalized tonic-clonic seizures. Diagnosis was based on clinical features and a rapid response
to thiamine replacement with adequate control of seizures. This clinical entity and its association with epilepsy is
extremely rare and must be thought of amongst the differentials of megaloblastic anemia and epilepsy. This rare case
emphasizes the unique association of TRMA with epilepsy. Early diagnosis and management with thiamine drastically
improves anemia, seizure control and blood glucose levels. To the best of our knowledge, it is the first case report of
TRMA with epilepsy from Pakistan.
KEYWORDS: TRMA, Rogers syndrome, SLC19A2 mutation, Megaloblastic anemia, Epilepsy
INTRODUCTION:
In 1969 this rare clinical entity thiamine responsive
-megaloblastic-anemia (TRMA) or Rogers syndrome
was first penned down by Rogers,et al with clinical triad
of megalo-blastic anemia, diabetes-mellitus and
sensory-neural hearing-loss showing remarkable
response to thiamine supplementation [1]. Its genetic
predisposition is due to mutation of SLC19A2 which is
used for the
high-affinity-thiamine-transporter-1
(h-THTR1), through this route thiamine is delivered to
different cells and tissues e.g. ß-cells of pancreas,
cochlear-cells,
haemopoietic
tissues,
and
retinal-epithelial cells [2]. Due to this deficiency of
thiamine-transport system the cells and tissues are
unable to utilize thiamine from the diet for their normal
functioning thus causing low concentrations of
thiamine in the body and eventually cell death. TRMA is
a very rare entity with only a few well documented
cases worldwide. [3]. Thiamine’s active form is
thiamine-diphosphate which acts as a co-factor for
enzymes like pyruvate-dehydrogenase, transketolase
and alpha-ketoglutarate all of which contribute in the
hexose-monophosphate cycles which generate
nicotinamide-adenine-dinucleotide-phosphate
for
nucleic-acid-synthesis. These enzymes are needed for
catabolism of carbohydrates and thiamine is needed for
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the production of acetylcholine and gamma-amino-buy
ric-acid which act as neuro-transmitters [4]. The onset of
TRMA is usually at infancy or childhood. Megaloblastic
anemia is usually corrected with life-long use of
thiamine at 25-75mg/day rather than recommended
daily dosage of thiamine 1.5mg/day; it is important to
note that anemia can persist once thiamine is stopped.
Sensory-neural deafness is reported to be permanent
and does not resolve with thiamine supplementation
since h-THTR1 is located on cochlear cells and the
mutation results in permanent cochlear neuropathy [5].
Thiamine has been proposed to cause remission of
diabetes in such patients with less insulin requirement
but some reports have also described keto-acidosis
with TRMA due to apoptosis of beta cells of pancreases
thus requiring insulin with thiamine to control diabetes
[6].
In normal population where no genetic mutation is
seen but they have thiamine deficiency due to severe
mal-nourishment their clinical features consist of
lethargy, easy fatiguability, mild neurological and
gastro-intestinal symptoms. Later in life they can suffer
from beriberi, peripheral neuropathy, absent position
and vibration sense, absent deep-tendon reflexes,
muscle cramps, cardiomyopathy and psychological
manifestations [7]. It could also be complicated with
optic-nerve atrophy,
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ptosis, hoarseness of voice, muscular atrophy,
meningismus, ataxia, loss of deep sensations and
sometimes coma [7]. In patients with TRMA due to
genetic mutations there is decreased production of
nucleic-acids thus causing molecular and biochemical
disturbances leading to cell arrest and apoptosis inside
bone marrow thus depicting manifestations of TRMA.
Other associated manifestations of TRMA include
myelodysplasia, congenital heart defects (patent
ductus arteriosus), arrhythmias, ischemic stroke and
retinal abnormalities e.g. retinitis pigmentosa, cone-rod
dystrophy and optic atrophy etc[8].We report a rare case
of a 13 year old boy who presented with seizures and
was later diagnosed to have TRMA. Seizures with TRMA
are rare and an unusual manifestation of Rogers
syndrome. To our knowledge this is the first case of
TRMA with epilepsy from Pakistan.

inquiring his father provided with a lead that one of his
son’s paternal-cousins had the same disease.
Therefore, considering his past history and examination
we put TRMA as the top clinical differential and
investigated him. Upon investigations his blood picture
showed a hemoglobin of 9g/dl (normal range: 14-18),
blood indices showed mean-corpuscular-volume MCV
was 106 fl (normal range:82-90), mean-corpuscular
hemoglobin was 34.3 pg(normalrange:27-32)
,mean-corpuscular-hemoglobin concentration was
32.5g/dl (normal range:32-36). White blood cells were
9x109/L
and
platelet
count
394x109/L.
Erythrocyte-sedimentation rate was 11mm/1st hour.
Peripheral blood film showed macrocytosis with hyper
segmented neutrophils. Serum ferritin was 380 ng /ml
(normal
range:10-308
ng/ml),
Total
ironbinding-capacity
was
42.2
umol/L
(normal
range:42.96-80.55 umol/L), serum iron was 161 ug/dL
(normal range:30-159), reticulocyte count showed
0.6% retics and hemoglobin electrophoresis showed no
abnormality. Serum Vitamin B12 levels were 550 pg./
mL (normal range: 221-920) while serum folate levels
were 18 ng/ mL (normal range: 4-17). Bone marrow
aspiration with trephine biopsy showed normo-cellular
bone marrow with megaloblastic changes (Figure A).
Osmotic fragility showed no abnormality and Coomb’s
direct and indirect test was negative. Fasting blood
glucose levels were 230 mg/dL while hemoglobin A1c
was 11%. Liver and renal functions were normal.
Serum levels of Vitamin-D, calcium and thyroid profile
was normal. Hepatitis B and C serologies were
negative. Arterial blood gases showed no abnormality
and urinary/serum ketones showed no evidence of
keto-acidosis. Fundoscopy and slit lamp examination
showed no retinal abnormality. Electrocardiogram and
echocardiogram showed no valvular abnormality with
sinus rhythm. Ultrasound abdomen showed no
organomegaly or ascites. Chest Xray was
unremarkable. maging of the brain (MRI brain) was
done which showed no acute or chronic pathology while
electroencephalogram (EEG) hyper-ventilation induced
generalized spike burst 1-2 sec with normal
background rhythm (Figure B).On the basis of
significant history, clinical examination and laboratory
findings he was diagnosed to have Rogers
syndrome/TRMA. Oral thiamine supplementation was
started at 250 mg daily with multi-vitamin
supplementation. Insulin was started at 0.7units/kg
subcutaneously. For seizures he was started on
carbamazepine 200mg twice daily. After four weeks of
follow up he remained seizure free on carbamazepine,
hemoglobin level

CASE PRESENTATION:
A 13 year old boy came to Neurology out patient
department with history of loss of consciousness
succeeded by frothing from mouth, abnormal jerking of
the body and sphincter incontinence for the past 6
months. Initially he was taken to a local spiritual healer
by his parents but no improvement was seen in his
symptoms, then he was taken to a Pediatrician who
eventually referred him to us for the evaluation of
seizures. Upon inquiring his mother, they had a single
child with a consanguineous marriage. He was born at
a local dispensary through normal vaginal delivery with
normal cry at birth. Being a new born, he was noted to
have lethargy, generalized weakness and extreme pallor
for which frequent help was sought. At that time based
on his blood peripheral film and bone marrow biopsy he
was diagnosed to have megaloblastic anemia and
received his first blood transfusion at the age of 12
months. Since then he would require monthly blood
transfusions with red cell concentrates. At the age of
2.5 years his parents noted hearing impairment and
lack of attention when confronted, medical help was
sought and he was diagnosed to have a sensory-neural
deafness. Therefore, he received his early education at
a special children school. At the age of 13 years, he
started having episodes of loss of consciousness with
post-ictal confusion and sphincter disturbance. On
general physical examination he had normal vital signs.
He looked extremely weak and pale but no cyanosis,
jaundice, clubbing, leukonychia or koilonychias was
seen. His height and weight was well below third
percentile and his body mass index was 16.2 signifying
being underweight. Tuning fork test showed a bilateral
sensory-neural deafness while all other systemic
examination showed no abnormality. During further
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increase from 9 to 12g/dl while MCV dropped from 105
to 99 fl. After 12 months of follow up his hemoglobin
levels remained static at 12g/dl with no transfusions. His
weight and height reached third centile for his age.
HbA1c levels dropped from 12 to 8.5%. Patient’s insulin
dose was reduced and continued with carbamazepine
200mg twice daily, thiamine 100mg daily, multi-vitamins
and dietary/life style modifications were explained to
family regarding his diabetes. Unfortunately, there was
no improvement in his hearing for which he was referred
to ENT specialist for cochlear implants.

Figure A: Normo-cellular bone marrow with megaloblastic
erythropoiesis

Figure B: Hyper-ventilation induced generalized spike and
wave discharges with normal background rhythm.

DISCUSSION:
Rogers syndrome or TRMA is an autosomal recessive
disorder with clinical constellation of sensory-neural
deafness, megalo-blastic anemia and diabetes mellitus.
It occurs due to mutation of SLC19A2 gene which is
responsible for the high-affinity-thiamine-transporter-1

PAKISTAN JOURNAL OF NEUROLOGICAL SCIENCES

25

(h-THTR1) used for transporting thiamine to tissues [9].
Our 13 year old patient had persistent anemia since early
life with deafness and required blood transfusions due to
megaloblastic picture with normal B12/folate levels. In
TRMA megaloblastic anemia must be differentiated from
other common causes like B12/folate deficiency and
some rare causes like orotic-aciduria. Orotic-aciduria
causes megaloblastic anemia due to deficient pyrimidine
synthesis leading to reduced lipid co-factors required for
red cell membrane synthesis; it also shows mental
retardation, growth-failure and raised urinary orotic acid
[10].
Other differential diagnosis with similar phenotype
include DIDMOAD syndrome (diabetes-insipidus,
diabetes-mellitus, optic-atrophy, and deafness) showing
diabetes insipidus a clue to diagnosis without anemia;
Kearns Sayre syndrome has chronic progressive external
ophthalmoplegia with retinopathy and deafness and
Pearson syndrome has persistent sideroblastic
pancreatic insufficiency and pancytopenia both
classifying as mitochondrial disorders which don’t exhibit
megaloblastic anemia, bone marrow biopsy is normal
and do not show response to thiamine therapy. The
pattern of mitochondrial disorders is maternal while
TRMA is autosomal recessive. In our patient bone
marrow showed a normo-cellular picture with
megaloblastic changes in erythropoiesis but TRMA can
be confused with myelodysplasia of pre malignancy [11].
Our patient was started on daily thiamine
supplementation of 250mg daily which was the only high
dose formulation available. His hemoglobin levels
improved drastically over a period of four weeks.
Although in our case anemia showed response to
thiamine supplementation but the macrocytosis did not
revert indicating that the red cells maintain their
macrocytic ability due to permanent erythropoietic
aberration and anemia can recur once thiamine is
stopped. Diabetes in this disease is non-autoimmune
type and may start as type 2 and then gradually progress
to insulin-dependency due to insulin deficiency
secondary to dysfunction of islet cells [12]. TRMA patients
show normal insulin secretion to glucose intake and have
normal C-peptide-secretions. Such patients respond to
thiamine supplementation thus reducing the dose of
insulin but most patients require insulin for life time after
puberty [12]. Diabetic keto acidosis could be the very first
presentation of such patients or once thiamine therapy is
stopped [12]. Thiamine shows a remarkable response to
disturbed hematological parameters with improvement in
diabetic control but deafness is permanent with no
response to thiamine treatment however some studies
suggest that early diagnosis and treatment could partially
reverse sensory-neural deafness in humans [13]. Our
patient’s HbA1c dropped from 12 to 8.5% after 12
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months of thiamine therapy with decline in insulin dose
which is remarkable improvement in glycemic control.
Insulin dependence could be due to high insulin
requirement during puberty and late diagnosis thus late
thiamine initiation which did not reverse his glycemic
indices to normal. Our patient started experiencing
seizures and showed reduction in seizure frequency with

CONCLUSION: Rogers syndrome must be thought of
amongst the differentials of megaloblastic anemia, diabetes
and hearing loss just like our patient who was suspected on
clinical acumen including laboratory tests, thiamine
responsive anemia and decrease in HbA1c with reduction in
insulin dose signifies the effects of thiamine on glycemic
control. Deafness showed no response while epilepsy showed
partial response to thiamine and complete response to
anti-epileptic drugs. Based on clinical diagnosis thiamine
should be given prophylactically in all such patients
presenting with clinical triads and non-availability of genetic
analysis. Thiamine has an economical price and response can
easily be observed after its initiation. This clinical entity and
its association with epilepsy is extremely rare and must be
thought of amongst the differentials of megaloblastic anemia
and epilepsy specially in countries like Pakistan where there is
a high background of consanguinity.

carbamazepine thus was diagnosed TRMA with epilepsy
because his seizures were not hypo-glycemic or metabolic.
They represent an un-usual manifestation of this disease.
Treatment of TRMA is life long thiamine therapy at
25-75mg/day. Patients should be followed up to see
compliance to oral thiamine as well as to see disease
progression with yearly blood counts, retic count, glucose
intolerance tests, urine analysis, hearing, cardiac and
ophthalmological evaluations [14].
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